(Y52) Agents primarily affecting the cardiovascular system

More details coming soon

Icon
72 652 in individuals diagnosis agents primarily affecting the cardiovascular system confirmed
Icon
1 277 deaths with diagnosis agents primarily affecting the cardiovascular system
Icon
2% mortality rate associated with the disease agents primarily affecting the cardiovascular system

Diagnosis agents primarily affecting the cardiovascular system is diagnosed Women are 16.51% more likely than Men

30 329

Men receive the diagnosis agents primarily affecting the cardiovascular system

634 (2.1 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
42 323

Women receive the diagnosis agents primarily affecting the cardiovascular system

643 (1.5 %)

Died from this diagnosis.

Risk Group for the Disease agents primarily affecting the cardiovascular system - Men aged 60-64 and Women aged 75-79

Icon
In Men diagnosis is most often set at age 0-5, 10-14, 30-34, 50-64, 70-89
Icon
Less common in men the disease occurs at Age 0-1, 5-9, 15-29, 35-49, 65-69, 90-95+Less common in women the disease occurs at Age 0-19, 25-29, 55-59, 95+
Icon
In Women diagnosis is most often set at age 20-24, 30-54, 60-94

Disease Features agents primarily affecting the cardiovascular system

Icon
Absence or low individual and public risk
Icon

Agents primarily affecting the cardiovascular system - what does this mean

Cardiovascular diseases occur when the heart or blood vessels are damaged, leading to reduced or blocked blood flow. this can be caused by a variety of factors, including high blood pressure, high cholesterol, smoking, diabetes, obesity, physical inactivity, and genetic factors. these agents can damage blood vessels, leading to narrowing of the vessels, plaque buildup, and eventual blockage, leading to a heart attack or stroke.

What happens during the disease - agents primarily affecting the cardiovascular system

The primary pathogenesis of the disease agents primarily affecting the cardiovascular system is a disruption of the normal functioning of the heart and blood vessels due to a variety of factors, such as genetic predisposition, environmental exposures, lifestyle choices, and underlying medical conditions. these factors can lead to an increase in the risk of developing conditions such as hypertension, coronary artery disease, and stroke, which can cause serious and potentially life-threatening complications.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Blood tests
  • Electrocardiogram (ECG)
  • Stress test
  • Echocardiogram (ECHO)
  • Cardiac catheterization
  • Cardiac MRI
  • Coronary angiography
  • Cardiac CT scan
  • Cardiac biopsy

Treatment and Medical Assistance

The main goal of the treatment is to reduce the risk of cardiovascular disease and improve the overall health of the patient.
  • Regular physical activity
  • Healthy diet
  • Quitting smoking
  • Maintaining a healthy weight
  • Limiting alcohol consumption
  • Managing stress levels
  • Monitoring blood pressure and cholesterol levels
  • Taking prescribed medications
Icon
11 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Agents primarily affecting the cardiovascular system - Prevention

The best way to prevent diseases that primarily affect the cardiovascular system is to maintain a healthy lifestyle, including regular exercise, a balanced diet, and avoiding smoking and excessive alcohol consumption. additionally, regular check-ups with a doctor are recommended to monitor blood pressure, cholesterol, and other markers of cardiovascular health.

Specified forms of the disease

(Y52.0) Cardiac-stimulant glycosides and drugs of similar action
(Y52.1) Calcium-channel blockers
(Y52.2) Other antidysrhythmic drugs, not elsewhere classified
(Y52.3) Coronary vasodilators, not elsewhere classified
(Y52.4) Angiotensin-converting-enzyme inhibitors
(Y52.5) Other antihypertensive drugs, not elsewhere classified
(Y52.6) Antihyperlipidaemic and antiarteriosclerotic drugs
(Y52.7) Peripheral vasodilators
(Y52.8) Antivaricose drugs, including sclerosing agents
(Y52.9) Other and unspecified agents primarily affecting the cardiovascular system